Search Hotels in Sausalito

STAAR Surgical Publishes Presentation Highlighting Compelling, Certain Cash Value Offered by Alcon Merger and Meaningful Downside Risks if Alcon Merger is not Approved

September 26, 2025

STAAR Surgical has been on fire lately. In the past six months alone, the company’s stock price has rocketed 52.2%, reaching $26.75 per share. This was partly thanks to its solid quarterly results, and...

3 Reasons to Avoid STAA and 1 Stock to Buy Instead

September 26, 2025

STAAR Surgical’s Shareholder Yunqi Capital Opposes Proposed Merger With Alcon – Here’s Why

September 22, 2025

Via Stocktwits

Broadwood Partners Files Definitive Proxy Statement Soliciting STAAR Surgical Stockholders to Vote “AGAINST” Proposed Acquisition by Alcon

September 24, 2025

From Broadwood Partners, L.P.

STAAR Surgical Announces Expiration of “Window Shop” Period; No Competing Acquisition Proposals Received

September 22, 2025

Yunqi Capital, 5.1% Holder and One of STAAR Surgical Company’s Largest Shareholders, Announces Intention to Vote Against the Proposed Sale to Alcon

September 22, 2025

From Yunqi Capital Limited

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PGRE, ETNB, STAA on Behalf of Shareholders

September 20, 2025

STAAR Surgical Board of Directors Unanimously Believes Alcon Merger Maximizes Value for STAAR Stockholders

September 16, 2025

Shareholder Alert: The Ademi Firm Continues to Investigate Whether STAAR Surgical Company Is Obtaining a Fair Price for Its Public Shareholders

September 15, 2025

From The Ademi Firm

Medical Devices & Supplies - Specialty Stocks Q2 Earnings: STAAR Surgical (NASDAQ:STAA) Firing on All Cylinders

September 14, 2025

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the medical devices & supplies - specialty stocks, including STAAR Surgical (NASDAQ:STAA) and its peers.

STAA Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of STAAR Surgical Company is Fair to Shareholders

September 11, 2025

STAAR Surgical Reiterates Compelling, Premium Cash Value Provided by Alcon Merger

September 02, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,...

1 Healthcare Stock with Solid Fundamentals and 2 We Avoid

September 02, 2025

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to...

Topics Stocks

3 Stocks Under $50 Walking a Fine Line

August 26, 2025

The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher...

1 Russell 2000 Stock with Exciting Potential and 2 Facing Challenges

August 25, 2025

"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated...

1 High-Flying Stock to Target This Week and 2 We Avoid

August 22, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DAY, WOW, YMAB, STAA on Behalf of Shareholders

August 21, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Dayforce, Inc. (NYSE- DAY), WideOpenWest, Inc. (NYSE - WOW), STAAR Surgical Company (Nasdaq – STAA), Y-mAbs Therapeutics, Inc. (Nasdaq – YMAB)

August 21, 2025

From Brodsky & Smith LLC

Having a stock you own get acquired at a premium feels good at first, but what about the long-term gains that will be left behind when your chips are off the table?

Predicting the Next Rule Breaker Buyout

August 19, 2025

Via The Motley Fool

Topics Artificial Intelligence

August 15, 2025

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other...

Penumbra, STAAR Surgical, CONMED, Acadia Healthcare, and Select Medical Shares Are Soaring, What You Need To Know

Topics Supply Chain

August 13, 2025

A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: WideOpenWest, Inc. (NYSE - WOW), BankFinancial Corporation (Nasdaq - BFIN), STAAR Surgical Company (Nasdaq – STAA), Y-mAbs Therapeutics, Inc. (Nasdaq – YMAB)

Topics Economy

August 12, 2025

From Brodsky & Smith LLC

Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital...

1 Unprofitable Stock to Consider Right Now and 2 Facing Headwinds

August 11, 2025

Shareholder Alert: The Ademi Firm Investigates Whether STAAR Surgical Company Is Obtaining a Fair Price for Its Public Shareholders

August 08, 2025

From Ademi & Fruchter LLP

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PHLT, AMWD, STAA on Behalf of Shareholders

August 07, 2025

STAAR SURGICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of STAAR Surgical Company - STAA

This Campbell's Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

August 07, 2025

Via Benzinga

August 07, 2025

From Kahn Swick & Foti, LLC

Medical lens company STAAR Surgical (NASDAQ:STAA) announced better-than-expected revenue in Q2 CY2025, but sales fell by 55.2% year on year to $44.32 million. Its GAAP loss of $0.34 per share was 49.9%...

Beyond The Numbers: 5 Analysts Discuss Staar Surgical Stock

August 07, 2025

Via Benzinga

STAAR Surgical (NASDAQ:STAA) Delivers Strong Q2 Numbers

August 06, 2025